Aerogen – Breathing New Life Into Aerosol Drug Delivery

By John McManus

“Aerogen is the first company in the world to develop technologies for high-performance aerosol drug delivery in acute care,” says founder and CEO John Power. The company has established itself as the global market leader in acute care drug delivery for ventilated patients. Strategic partnerships with leading companies in the sector played an important role in the acceptance of Aerogen’s innovative nebuliser technology for application in aerosol drug delivery.


Search LESI

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors